In a diabetic MI model, AAV9-mediated cardiac-specific FSTL1 expression significantly reduced apoptosis and fibrosis, underscoring both the therapeutic potential and the need for context-dependent modulation (Lu et al., 2021). This evidence concerns the gene FSTL1 and myocardial infarction.